Kester Capital

Frontier Medical announces appointment of Simon Jackson as Managing Director

01 August 2014

Frontier Medical, a leading UK supplier of medical devices and services to the healthcare sector, is pleased to announce the appointment of Simon Jackson as Managing Director.

A graduate in Mechanical and Biomedical Engineering, Simon began his career as a sales executive with Johnson & Johnson.  From there he progressed to GE Healthcare and then on to a UK and European leadership role with CR Bard.  In 2009 Simon joined Systagenix, a UK-headquartered global wound care business backed by One Equity Partners.  Simon was responsible for the European sales and marketing business (USD$100m of sales) before joining Frontier Medical as a Director in March 2014.


Contact us:

Kester Capital:     
Cameron Crockett or Jeniv Shah / +44 20 3747 5700
Frontier Medical: 
Simon Jackson /

About Kester Capital

Kester Capital is a mid-market UK private equity firm investing in businesses with an enterprise value of £10-50 million. It was established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co.

About Frontier Medical

Frontier is a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and internationally. Frontier’s portfolio of highly regarded brands includes: Repose, a range of leading pressure area care devices; Sharpsafe, premium quality sharps disposal containers; and eXchange, specialist harm reduction products and services. Pressure area care and infection control have emerged as areas of serious concern for healthcare providers across the world and Frontier has an enviable track record of helping its customers deal with these growing issues both in the UK and overseas.